Live Breaking News & Updates on Meets Primary End

Survival outcomes following curative resection in resectable NSCLC have been poor and, until recently, the main tool oncologists had at their disposal was neoadjuvant or adjuvant chemotherapy. ....

United States , Perioperative Pembrolizumab Keytruda , Samuel Rosner , Neoadjuvant Nivolumab Opdivo , University Of Maryland Greenebaum Comprehensive Cancer Center , Annual Winter Lung , Maryland Greenebaum Comprehensive Cancer Center , Meets Primary End , Annual Winter Lung Cancer Conference , Per Winter Lung Cancer Conference , Lung Cancer ,